Pharmacological Properties of DOV 315,090, an ocinaplon metabolite

BACKGROUND: Compounds targeting the benzodiazepine binding site of the GABA(A)-R are widely prescribed for the treatment of anxiety disorders, epilepsy, and insomnia as well as for pre-anesthetic sedation and muscle relaxation. It has been hypothesized that these various pharmacological effects are...

Descripción completa

Detalles Bibliográficos
Autores principales: Berezhnoy, Dmytro, Gravielle, Maria C, Downing, Scott, Kostakis, Emmanuel, Basile, Anthony S, Skolnick, Phil, Gibbs, Terrell T, Farb, David H
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2529273/
https://www.ncbi.nlm.nih.gov/pubmed/18554397
http://dx.doi.org/10.1186/1471-2210-8-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2529273/
https://www.ncbi.nlm.nih.gov/pubmed/18554397
http://dx.doi.org/10.1186/1471-2210-8-11

Ejemplares similares